Harvey Jones was looking forward to a Santa Rally in December, but it looks like we're not going to get one this year.

Based on data from MarketBeat, GSK has an average rating of “Moderate Buy” and a consensus target price of $43.25. Shares of ...

The main aim of stock picking is to find the market-beating stocks. But the main game is to find enough winners to ...

GSK said on Friday the addition of its cancer drug Jemperli to both standard of care chemotherapy and Zejula maintenance ...

Though GSK is definitely not the best large-cap drugmaker to have in one's portfolio, we believe there is potential for its ...

By posting on our share chat boards you are agreeing to the ... I've done a search for relevent news on GSK today. I'm not sure if this is news, or relevant, so forgive me for posting it if ...

The GSK (GSK.L) share price has fallen off its perch. So it may be a good time to research and consider the stock opportunity. I think the global biopharma company has been dripping with promise for a ...

GSK plc stock is downgraded due to litigation risks, weak sales, and market pressures, dividend yield remains a bright spot. Click for more on GSK stock.

(Alliance News) - GSK PLC on Friday said a trial of two ovarian cancer treatments met its primary endpoint but did not meet a key secondary target. The First-Engot-OV44 phase III trial evaluated ...

Market no longer bothers to respond to positive news from GSK. I have asked IR repeatedly ... given the company’s strategy to pay out 60% of FCF. - Share Price Potential: The share price is ...